CAS 42490-70-4
Weight Management & GLP-1
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it increases intracellular NAD+ and SAM levels, promoting metabolic activity in adipocytes. Research…
View compound details →
CAS 221231-10-3
Weight Management & GLP-1
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) studied for its lipolytic effects without the diabetogenic or growth-promoting activity of full-length…
View compound details →
CAS 2375218-57-8
Weight Management & GLP-1
Mazdutide is a dual GLP-1/glucagon receptor agonist that combines GLP-1-mediated appetite suppression with glucagon receptor activation for increased hepatic energy expenditure. Clinical research examines obesity,…
View compound details →
CAS 2381089-83-2
Weight Management & GLP-1
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors, making it one of the most closely watched molecules in metabolic research. WBP…
View compound details →
CAS 910463-68-2
Weight Management & GLP-1
Semaglutide is a long-acting GLP-1 receptor agonist extensively studied in metabolic and obesity research. WBP offers research-grade semaglutide synthesized under cGMP protocols with full analytical…
View compound details →
Weight Management & GLP-1
SLU-PP-332 is a small-molecule ERR agonist that mimics the transcriptional effects of endurance exercise. It activates ERR-alpha, -beta, and -gamma to upregulate genes involved in…
View compound details →
CAS 2375218-79-4
Weight Management & GLP-1
Survodutide is a dual glucagon/GLP-1 receptor agonist. It activates glucagon receptors to increase energy expenditure and GLP-1 receptors to reduce appetite and improve glycemic control.…
View compound details →
CAS 402856-42-2
Weight Management & GLP-1
Tesofensine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that suppresses appetite, increases thermogenesis, and reduces fat mass. Clinical trials demonstrated significant weight loss effects. Research continues…
View compound details →
CAS 2023788-19-2
Weight Management & GLP-1
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist under intensive investigation for metabolic disease and obesity research. WBP supplies cGMP-synthesized tirzepatide with comprehensive…
View compound details →